Form 4: Arteris VP Sells Shares After Option Exercise

Arteris, Inc.'s VP and General Counsel, Paul L. Alpern, exercised stock options and subsequently sold 5,000 shares of common stock under a pre-arranged 10b5-1 plan.

Summary

• Paul L. Alpern, VP and General Counsel of Arteris, Inc. (AIP), engaged in a pre-planned transaction on December 1, 2025.
• Alpern exercised options to acquire 5,000 shares of common stock at an exercise price of $0.56 per share.
• Immediately following the exercise, Alpern sold 5,000 shares of common stock at a weighted average price of $14.2989 per share.
• The sale price for these shares ranged from $13.70 to $14.66.
• These transactions were conducted under a Rule 10b5-1 trading plan adopted on June 5, 2025.
• Following these transactions, Alpern beneficially owns 65,960 shares of common stock directly and 75,000 derivative securities (options).

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While an insider sale can sometimes be viewed negatively, the execution under a 10b5-1 plan mitigates concerns about opportunistic selling. The significant profit from option exercise is a positive for the executive, but the reduction in direct share ownership is a minor negative for market perception.

Positives

• The transactions were executed under a Rule 10b5-1 trading plan, indicating pre-planned activity and potentially reducing concerns about insider trading based on non-public information.
• The sale price of $14.2989 per share represents a significant gain over the exercise price of $0.56 per share, indicating a profitable transaction for the insider.

Negatives

• An insider sale, even under a 10b5-1 plan, can sometimes be interpreted by the market as a lack of confidence in the company's near-term stock price appreciation, although this is not always the case.
• The reduction in direct beneficial ownership of common stock by 5,000 shares.

Future Outlook

NA

Management Comments

• The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Industry Context

This Form 4 filing details an individual executive's stock transactions and does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders: May interpret the sale as a signal, though mitigated by the 10b5-1 plan. The executive's profitable exercise and sale could be seen as a positive for executive compensation alignment.

Key Dates

Recommendation

This Form 4 filing reports a routine, pre-planned insider transaction (exercise of options and subsequent sale of shares) by a VP and General Counsel. While an insider sale reduces direct ownership, the execution under a 10b5-1 plan suggests it's part of a personal financial strategy rather than a reaction to new, negative information. The transaction itself does not provide new fundamental information about Arteris, Inc.'s operational performance or future prospects to warrant a change in investment thesis. Therefore, a 'hold' recommendation is appropriate as this filing alone does not present a compelling reason to buy or sell.

Keywords

Arteris Inc., AIP, Paul L. Alpern, Insider Trading, Form 4, Stock Options, 10b5-1 Plan, Share Sale, Executive Compensation